Nature Reviews Cardiology

Papers
(The H4-Index of Nature Reviews Cardiology is 71. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension699
Interplay between inflammation and thrombosis in cardiovascular pathology469
The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease459
PPAR control of metabolism and cardiovascular functions434
Smart wearable devices in cardiovascular care: where we are and how to move forward424
Artificial intelligence-enhanced electrocardiography in cardiovascular disease management415
Global epidemiology of dyslipidaemias411
Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases378
Epidemiology of cardiovascular disease in Europe356
Pathophysiology of sepsis-induced cardiomyopathy329
Global epidemiology of valvular heart disease320
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation298
Transportation noise pollution and cardiovascular disease284
Epicardial adipose tissue in contemporary cardiology277
Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis264
Cellular and molecular pathobiology of heart failure with preserved ejection fraction234
The role of cardiac rehabilitation in improving cardiovascular outcomes224
Epidemiology and management of aortic disease: aortic aneurysms and acute aortic syndromes224
Ceramides and other sphingolipids as drivers of cardiovascular disease200
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium199
Heart failure with mid-range or mildly reduced ejection fraction191
Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?190
Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging182
Optical coherence tomography in coronary atherosclerosis assessment and intervention180
Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms178
Systems biology in cardiovascular disease: a multiomics approach172
Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches169
Vascular endothelial cell development and diversity157
Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action146
Sit less and move more for cardiovascular health: emerging insights and opportunities145
Transforming growth factor-β in myocardial disease138
Mechanisms and consequences of endothelial cell senescence137
Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease135
The quiescent endothelium: signalling pathways regulating organ-specific endothelial normalcy135
Blood pressure and its variability: classic and novel measurement techniques134
Obesity and the risk of cardiometabolic diseases130
The role of cellular senescence in cardiac disease: basic biology and clinical relevance127
Epidemiology and prevention of venous thromboembolism126
Genomics of hypertension: the road to precision medicine119
High-density lipoproteins, reverse cholesterol transport and atherogenesis118
Genomic frontiers in congenital heart disease118
Apolipoproteins in vascular biology and atherosclerotic disease117
Epidemiology and modifiable risk factors for atrial fibrillation116
The role of mitochondrial fission in cardiovascular health and disease114
Climate change and cardiovascular disease: implications for global health114
Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia108
Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development107
Cardiac optogenetics: a decade of enlightenment106
Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology104
Applications of artificial intelligence in cardiovascular imaging102
Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention99
Sulfide regulation of cardiovascular function in health and disease98
Update on the pathophysiology and medical treatment of peripheral artery disease98
Branched-chain amino acids in cardiovascular disease92
Cardiovascular risks of climate change88
RNA-targeting and gene editing therapies for transthyretin amyloidosis87
A fresh look at coronary microembolization84
Myocardial stunning and hibernation revisited84
Clinical utility of polygenic risk scores for coronary artery disease83
Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes82
Bleeding avoidance strategies in percutaneous coronary intervention82
Social determinants of atrial fibrillation81
Macrophages in cardiac remodelling after myocardial infarction81
Cardiac involvement in the long-term implications of COVID-1981
Plaque erosion and acute coronary syndromes: phenotype, molecular characteristics and future directions79
International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia79
Prevention of atherosclerosis from childhood77
Obstructive sleep apnoea heterogeneity and cardiovascular disease75
Targeted delivery of therapeutic agents to the heart75
Hallmarks of cardiovascular ageing74
Interactions between erectile dysfunction, cardiovascular disease and cardiovascular drugs71
0.042398929595947